Skip to content

Research at St Andrews

Rapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak

Research output: Contribution to journalArticle

DOI

Author(s)

Claudio U. Koeser, Matthew Thomas Geoffrey Holden, Matthew J. Ellington, Edward J. P. Cartwright, Nicholas M. Brown, Amanda L. Ogilvy-Stuart, Li Yang Hsu, Claire Chewapreecha, Nicholas J. Croucher, Simon R. Harris, Mandy Sanders, Mark C. Enright, Gordon Dougan, Stephen D. Bentley, Julian Parkhill, Louise J. Fraser, Jason R. Betley, Ole B. Schulz-Trieglaff, Geoffrey P. Smith, Sharon J. Peacock

School/Research organisations

Abstract

BACKGROUND

Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks.

METHODS

We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital.

RESULTS

We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial "resistome" of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a "toxome" consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain.

CONCLUSIONS

Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.)

Close

Details

Original languageEnglish
Pages (from-to)2267-2275
Number of pages9
JournalNew England Journal of Medicine
Volume366
Issue number24
DOIs
Publication statusPublished - 14 Jun 2012

    Research areas

  • RESISTANT STAPHYLOCOCCUS-AUREUS, MUTATIONS, EVOLUTION

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus

    Harrison, E. M., Ba, X., Coll, F., Blane, B., Restif, O., Carvell, H., Köser, C. U., Jamrozy, D., Reuter, S., Lovering, A., Gleadall, N., Bellis, K. L., Uhlemann, A. C., Lowy, F. D., Massey, R. C., Grilo, I. R., Sobral, R., Larsen, J., Rhod Larsen, A., Vingsbo Lundberg, C. & 5 othersParkhill, J., Paterson, G. K., Holden, M. T. G., Peacock, S. J. & Holmes, M. A., 24 Jun 2019, In : Nature Microbiology. 15 p.

    Research output: Contribution to journalArticle

  2. Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

    Davies, M. R., McIntyre, L., Mutreja, A., Lacey, J. A., Lees, J. A., Towers, R. J., Duchêne, S., Smeesters, P. R., Frost, H. R., Price, D. J., Holden, M. T. G., David, S., Giffard, P. M., Worthing, K. A., Seale, A. C., Berkley, J. A., Harris, S. R., Rivera-Hernandez, T., Berking, O., Cork, A. J. & 18 othersTorres, R. S. L. A., Lithgow, T., Strugnell, R. A., Bergmann, R., Nitsche-Schmitz, P., Chhatwal, G. S., Bentley, S. D., Fraser, J. D., Moreland, N. J., Carapetis, J. R., Steer, A. C., Parkhill, J., Saul, A., Williamson, D. A., Currie, B. J., Tong, S. Y. C., Dougan, G. & Walker, M. J., Jun 2019, In : Nature Genetics. 51, 6, p. 1035-1043

    Research output: Contribution to journalArticle

  3. Antimicrobial resistance in atopic dermatitis: need for an urgent rethink

    Harkins, C. P., Holden, M. T. G. & Irvine, A. D., Mar 2019, In : Annals of Allergy Asthma & Immunology. 122, 3, p. 236-240 5 p.

    Research output: Contribution to journalArticle

  4. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States

    Mohamed, N., Timofeyeva, Y., Jamrozy, D., Rojas, E., Hao, L., Silmon de Monerri, N. C., Hawkins, J., Singh, G., Cai, B., Liberator, P., Sebastian, S., Donald, R. G. K., Scully, I. L., Jones, C. H., Creech, C. B., Thomsen, I., Parkhill, J., Peacock, S. J., Jansen, K. U., Holden, M. T. G. & 1 othersAnderson, A. S., 14 Jan 2019, In : PLoS ONE. 14, 1, 33 p., e0208356.

    Research output: Contribution to journalArticle

Related by journal

  1. Five-year outcomes of a randomized trial of treatments for varicose veins

    Brittenden, J., Cooper, D., Dimitrova, M., Scotland, G., Cotton, S. C., Elders, A., MacLennan, G., Ramsay, C. R., Norrie, J., Burr, J. M., Campbell, B., Bachoo, P., Chetter, I., Gough, M., Earnshaw, J., Lees, T., Scott, J., Baker, S. A., Tassie, E., Francis, J. & 1 othersCampbell, M. K., 5 Sep 2019, In : New England Journal of Medicine. 381, p. 912-922

    Research output: Contribution to journalArticle

  2. Canakinumab for atherosclerotic disease

    MRC-ILA Heart investigators, Rothman, A. M., Morton, A. C. & Crossman, D. C., 11 Jan 2018, In : New England Journal of Medicine. 378, 2, p. 197-8 2 p.

    Research output: Contribution to journalArticle

  3. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa

    Hakim, J., Musiime, V., Szubert, A. J., Mallewa, J., Siika, A., Agutu, C., Walker, S., Pett, S. L., Bwakura-Dangarembizi, M., Lugemwa, A., Kaunda, S., Karoney, M., Musoro, G., Kabahenda, S., Nathoo, K., Maitland, K., Griffiths, A., Thomason, M. J., Kityo, C., Mugyenyi, P. & 5 othersPrendergast, A. J., Walker, A. S., Gibb, D. M., REALITY Trial Team & O'Hare, B. A-M., 20 Jul 2017, In : New England Journal of Medicine. 377, 3, p. 233-245 13 p.

    Research output: Contribution to journalArticle

  4. Safer prescribing - a trial of education, informatics, and financial incentives

    Dreischulte, T., Donnan, P., Grant, A., Hapca, A., McCowan, C. & Guthrie, B., 17 Mar 2016, In : New England Journal of Medicine. 374, 11, p. 1053-1064

    Research output: Contribution to journalArticle

  5. Therapy for Tuberculous Meningitis

    Boeree, M. J., Gillespie, S. H., Hoelscher, M. & PanACEA core team, 2 Jun 2016, In : New England Journal of Medicine. 374, 22, p. 2187-8 2 p.

    Research output: Contribution to journalLetter

ID: 74260530